Medidata White logo

Master the Next Generation of Clinical Research: 5 Strategies to Dramatically Improve Data Quality

May 8, 2024 - 11am (ET) / 10am (ET)

Webinar Medidata landing page
Medidata White logo

Master the Next Generation of Clinical Research: 5 Strategies to Dramatically Improve Data Quality

May 8, 2024 - 11am (ET) / 10am (ET)

Addressed Challenges

  • The top challenges organizations face when adopting an end-to-end clinical data quality strategy
  • Recommendations to overcome roadblocks, including technology and implementation best practices to make sure you avoid those challenges
  • Best practices on how to ensure successful adoption by end users

Learning Objectives

  • Move from manual, reactive data review and cleaning to proactive, risk-based approaches based on integrated data
  • Provide clinical data management and monitoring teams with workflows and analytics that support their day-to-day functions
  • Leverage technologies that incorporate AI to automate manual tasks and identify potential issues sooner

Ken Hamill

Senior Director Clinical Operation Portfolio, Medidata

Ken has worked within the Life Sciences technology space for over 16 years across discovery, preclinical, and clinical areas. At Medidata, his focus includes launching and commercializing solutions in trial management and risk-based quality management (RBQM) which streamline clinical execution processes. He works across the organization and with customers in their adoption of enabling technologies that enhance efficiency and deliver deeper insights to improve trial quality and patient safety. Ken is a subject matter expert on RBQM processes. Prior to Medidata Ken was a strategy director at PerkinElmer, where he led the commercialization of drug discovery assay solutions. Ken has an MBA and an MS in Chemistry.
Read More >>>

<span>By ticking this box, you consent to receiving communications from Medidata related to this topic and other products or services within their portfolio</span>

Dark